Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Hanaki

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Chemotherapy|November 1, 1996
In vitro and in vivo antibacterial activities of TOC-50, a new parenteral cephalosporin, against Enterococcus faecalisS Nomura, H Hanaki, T Furukawa, et al.
The Japanese Journal of Antibiotics|June 30, 1998
[Increase of non-amidated muropeptides in the cell wall of vancomycin-resistant Staphylococcus aureus (VRSA) strain Mu50]H Hanaki, H Labischinski, Y Inaba, et al.
International Journal of Antimicrobial Agents|May 29, 2004
Improved method of detection of beta-lactam antibiotic-induced VCM-resistant MRSA (BIVR)H Hanaki, Y Yamaguchi, K Barata, et al.
The Japanese Journal of Antibiotics|March 17, 1999
[In vitro susceptibilities of clinical isolates of coagulase-negative staphylococci to glycopeptide antibiotics]D Kato, H Hanaki, L Cui, et al.
Scandinavian Journal of Infectious Diseases|August 14, 1999
Postoperative toxic shock syndrome caused by a highly virulent methicillin-resistant Staphylococcus aureus strainL Cui, H Kasegawa, Y Murakami, et al.
The Japanese Journal of Antibiotics|September 19, 2001
[Effect of arbekacin on the production of toxic shock syndrome toxin 1 by methicillin-resistant Staphylococcus aureus]A Miyata, M Araake, H Ogawa, et al.
The Journal of Antibiotics|April 1, 1996
Structure-activity relationships of cephalosporin derivatives against methicillin-resistant Staphylococcus aureus and Enterococcus faecalisH Hanaki, H Akagi, S Nomura, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2000
Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50L Cui, H Murakami, K Kuwahara-Arai, et al.
The Journal of Antibiotics|July 25, 2000
Novel cephalosporins 2. Synthesis of 3-heterocyclic-fused thiopyranylthiovinyl cephalosporins and antibacterial activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalisH Yamazaki, Y Tsuchida, H Satoh, et al.
Nihon Kyobu Shikkan Gakkai Zasshi|March 1, 1987
[Usefulness of ultrasonography in lung cancer with atelectasis]I Usami, M Kato, H Kuroki, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Chemotherapy|November 1, 1996
In vitro and in vivo antibacterial activities of TOC-50, a new parenteral cephalosporin, against Enterococcus faecalisS Nomura, H Hanaki, T Furukawa, et al.
The Japanese Journal of Antibiotics|June 30, 1998
[Increase of non-amidated muropeptides in the cell wall of vancomycin-resistant Staphylococcus aureus (VRSA) strain Mu50]H Hanaki, H Labischinski, Y Inaba, et al.
International Journal of Antimicrobial Agents|May 29, 2004
Improved method of detection of beta-lactam antibiotic-induced VCM-resistant MRSA (BIVR)H Hanaki, Y Yamaguchi, K Barata, et al.
The Japanese Journal of Antibiotics|March 17, 1999
[In vitro susceptibilities of clinical isolates of coagulase-negative staphylococci to glycopeptide antibiotics]D Kato, H Hanaki, L Cui, et al.
Scandinavian Journal of Infectious Diseases|August 14, 1999
Postoperative toxic shock syndrome caused by a highly virulent methicillin-resistant Staphylococcus aureus strainL Cui, H Kasegawa, Y Murakami, et al.
The Japanese Journal of Antibiotics|September 19, 2001
[Effect of arbekacin on the production of toxic shock syndrome toxin 1 by methicillin-resistant Staphylococcus aureus]A Miyata, M Araake, H Ogawa, et al.
The Journal of Antibiotics|April 1, 1996
Structure-activity relationships of cephalosporin derivatives against methicillin-resistant Staphylococcus aureus and Enterococcus faecalisH Hanaki, H Akagi, S Nomura, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2000
Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50L Cui, H Murakami, K Kuwahara-Arai, et al.
The Journal of Antibiotics|July 25, 2000
Novel cephalosporins 2. Synthesis of 3-heterocyclic-fused thiopyranylthiovinyl cephalosporins and antibacterial activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalisH Yamazaki, Y Tsuchida, H Satoh, et al.
Nihon Kyobu Shikkan Gakkai Zasshi|March 1, 1987
[Usefulness of ultrasonography in lung cancer with atelectasis]I Usami, M Kato, H Kuroki, et al.
Pageof 5